Search for: "Nostrum Pharmaceuticals LLC v. FDA" Results 1 - 6 of 6
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 May 2011, 6:34 pm by FDABlog HPM
Karst –       Last Friday, Nostrum Pharmaceuticals, LLC (“Nostrum”) lodged a Complaint against FDA in the U.S. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
September 2021 FDA Recalls All Eco-Med ultrasound gels and lotions have been recalled by Eco-Med Pharmaceutical, Inc. due to the risk of bacterial contamination. [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV… [read post]
11 Jul 2008, 4:30 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]